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1 
Abstract 
Bacteriophage (phage) are viruses that infect and use bacterial hosts for viral 
replication. Study of these bacterial viruses has led to such discoveries as knowing DNA 
is the molecule of inheritance12. Study of phage has also led to discovery and 
implementation of novel therapeutic treatment of infections. Known as “phage therapy”, 
phage have been utilized in curing a patient of the highly virulent infection known as 
MRSA11. Tuberculosis, caused by Mycobacterium tuberculosis, is a growing concern as 
antibiotic-resistant strains become more prevalent in the population. Cepens is a lytic 
phage that infects members of the Mycobacterium genus. This study analyzes Cepens and 
its interactions with its host bacteria, Mycobacterium smegmatis, in an effort to 
understand how environmental conditions impact infection and replication efficiency. 
First, infection benchmarks were established by conducting a serial dilution and plaque 
assay under standard conditions. Baseline titer calculations were used for comparison 
after alteration of incubation temperature and pH of phage, both prior to and during 
infection. Extreme temperatures and pH were expected to lead to a decrease in infectivity 
as well as potential degradation of the phage itself. Analysis of this data indicates that 
extremes in either pH or temperature decrease phage viability as well as its ability to 
establish successful infection. 
  
2 
Introduction 
 Before the rise of antibiotics, a group of viruses known as bacteriophages (phage) 
were being studied for their effects on bacteria. Bacteriophage are viruses which infect 
bacterial cells, commonly causing the cell to lyse and release virions into the area 
surrounding the cell. These virions move on to infect more bacterial cells in the 
surrounding area. The continued release of virions leads to amplification of the virus and 
a decrease in viable bacterial cells. Ernest Hankin first published about phage in 1896. 
Hankin wrote about an unknown substance contributing to antibacterial activity in 
various rivers in India 1. Fredrick Twort later hypothesized that the antibacterial activity 
could be related to the processes of a virus. Twenty-one years later another scientist, 
Felix d’Herelle, was the first to test the virus phenomenon on humans and animals. After 
testing his mixtures on agar plates, d’Herelle was also the first to discover the clear areas 
that form when the virus is introduced to bacterial samples. These clear areas are now 
referred to as plaques1. After the parasitic nature of bacteriophages was realized, the 
phenomenon was expanded. d’Herelle started utilizing bacteriophages experimentally to 
treat human infections such as dysentery1. However, concerns with bacteriophage therapy 
rose after discovering their transduction capabilities, and the possibility of causing 
mutations in host cells6. After controversial opinions on bacteriophage use in humans and 
animals, along with the rise of antibiotics, the drive for research on bacteriophage therapy 
declined in most areas. However, in parts of the world such as Eastern Europe and the 
Soviet Union bacteriophage use continued therapeutically in combination with or in 
replacement of antibiotic treatment1.  
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 The recent push for the reintroduction of bacteriophage research is driven by the 
rise in antibiotic resistant bacterial pathogens. The initial incline of antibiotic use was due 
to their effectiveness, ability to treat a broad spectrum of bacterial infections, and 
stability6. However, researchers and medical professionals are now realizing that 
prolonged antibiotic use can lead to further increases in antibiotic resistance and damage 
to the gut biome, resulting in chronic enteric inflammatory diseases8. As a solution to this 
rising issue, bacteriophage can be used therapeutically in replacement of antibiotics to 
treat bacterial infections6. Bacteriophage therapy gains its effectiveness through the viral 
lifecycles, which can be classified two ways. If the bacteriophage inserts itself into the 
host genome forming a prophage then it is a lysogenic bacteriophage. The prophage is 
later excised and replicated to produce viral particles. This process can result in 
transduction which is harnessed to incorporate gene segments into pathogenic bacterial 
genomes2. On the other hand, if the bacteriophage enters the host cell and immediately 
uses the host machinery to start producing viral particles then it is considered a lytic 
bacteriophage. Lytic bacteriophage can be applied directly to infection sites to cause 
bacterial cell lysis3. Today, bacteriophages are also being used as model organisms for 
genetics research as well as studying temperate bacteriophages to be used in cancer 
treatments or mutation corrections3. 
This study focuses on mycobacteriophage, which are a classification of phage that 
specialize in infection of mycobacterial hosts. These bacteriophages are split into about 
30 clusters and infect microorganisms such as, Mycobacterium smegmatis, 
Mycobacterium Tuberculosis and Mycobacterium leprae1. Prior to this study, 
mycobacteriophage Cepens was isolated by Ethan Strickland on the University of North 
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Georgia campus in 2016. Cepens is a lytic cluster W mycobacteriophage from the 
Siphoviridae family. Members of this family have characteristic long non-contractile 
tails, and isometric heads13. Cepens forms 2mm clear round plaques, and transmission 
electron microscopy imaging shows a tail length of 235nm and head size of 52 nm. 
Cepens was isolated and studied using host organism M. smegmatis mc2155 (ATCC 
700084). Typically, M. smegmatis is used as a model organism for other pathogenic 
microorganisms from the mycobacteria family such as M. tuberculosis and M. leprae. M. 
smegmatis has a characteristic thick and waxy hydrophobic cell wall, similar to M. 
tuberculosis. It is also a generally nonpathogenic environmental species found in soils, 
and contributes to degradation of organic materials5. However, since 1986 there have 
been about 25 reported cases of M. smegmatis related infections in the soft tissue of the 
skin5. Use of M. smegmatis as a host organism allows researchers to learn more about the 
interactions of cluster W phages and mycobacterial pathogens without the dangers of 
working directly with those pathogens in the lab.  
Before bacteriophages can be used therapeutically, an effective method of 
administration must be determined. Most antibiotics are administered orally, however 
once the drug is ingested it becomes exposed to the increased acidity of the digestive 
system. If a bacteriophage is expected to be administered the same way, it would need to 
be capable of maintaining infectivity after exposure to the hostile conditions of the gut9. 
Also, the average internal body temperature of humans is 37 ˚C, so the bacteriophage 
must be able to successfully infect host cells at this temperature. Another primary 
concern is the temperature conditions under which the phage is capable of being stored 
until therapeutic use. Understanding the conditions in which bacteriophage Cepens is able 
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to maintain infectivity against M. smegmatis could shed light on potential administration 
methods and storage conditions during bacteriophage therapy. 
 
Methods 
M. smegmatis mc2155 (ATCC 700084) cells are cultured using Middlebrook 7H9 broth 
and shaken at an incubation temperature of 37˚C. Infections by Cepens are completed 
using lysate stored at 4 ˚C on sterile Difco Luria Agar plates at a pH of 6.5 using 1X soft 
top agar with the addition of CaCl2. For normal infection conditions, samples are 
incubated at 37 ˚C for 48 hours.  
Titer Calculations 
First, bacteria were serially diluted in a 1:10 fashion up to 10-7. After dilution, aliquots of 
10-5,10-6, and 10-7 were mixed with M. smegmatis, CaCl2 and 1X soft top agar then 
spread via swirling onto LB agar and plated in duplicate. Samples were incubated at 37˚C 
for 48 hours. After incubation, plaques were counted and averaged.  
M. smegmatis Growth Curve 
A standard curve of M. smegmatis was constructed to indicate the number of cells 
(colony forming units) present per ml of solution. This curve was generated by serial 
dilution plating and OD600 measurements. Samples were analyzed for colony number and 
absorbance at dilutions of 1:400-1:1600. First, M. smegmatis was inoculated and shaken 
in a 37 ˚C incubator for 48 hours. Next, the sample was aliquoted out and diluted in 7H9 
growth media. A spectrophotometer was used to determine the absorbance in each 
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dilution factor. Finally, each sample was plated in duplicate onto LB plates. After 
incubation at 37 ˚C, colonies were counted using the quadrant method.  
 
One step bacteriophage growth curve 
Cepens lysate was added at a multiplicity of infection of 1.0 to an aliquot of M. 
smegmatis at an OD of 0.4, and allowed to adsorb for 10 minutes. Next, the sample was 
centrifuged at 6000G for 10 minutes. Supernatant was removed and the pellet was 
resuspended in 7H9 growth media. The resuspended sample was centrifuged again at 
6000G for 10 minutes, and the supernatant was removed. Finally, sample was shaken at 
37 ˚C for six hours. Samples were plated in duplicate each hour.   
 
Temperature Stability of Lysate 
Cepens lysate was diluted to 10-5 and incubated at 4˚C, 37˚C, 45˚C, 55˚C, and 65 ˚C for 
two hours7. First, lysate was aliquoted into five sterile microcentrifuge tubes. After 
incubation, each aliquot was cooled to 4 ˚ C, and then added to M. smegmatis samples 
and allowed to adsorb for 10 minutes at room temperature and then plated in triplicate. 
Plates were incubated at 37 ˚C for 48 hours and then analyzed.  
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pH Stability of Lysate  
To determine the pH stability of bacteriophage Cepens, pH of 7H9 growth medium was 
adjusted using filter sterilized HCl and NaOH to pH levels of 2,3,5,7,9, and 10. Target 
pH values were confirmed using pH strips. Cepens lysate was incubated at each pH, 
undisturbed at room temperature for 24 hours7. Following treatment, M. smegmatis was 
infected with lysate and incubated at 37˚ C for 48 hours. Plaques were counted and 
averaged for each pH condition.  
 
Incubation Temperatures and Infection  
Cepens lysate was first added to M. smegmatis and allowed to adsorb for 10 minutes. 
Samples were plated in triplicate and incubated at 25˚C, 30˚C, 37˚C, 45˚C and 50 ˚C for 48 
hours. After incubation, average plaque numbers were used to calculate titer. 
 
pH and Infection 
Cepens was plated on plates with pH values between 5.0-8.1 and then incubated for 48h 
at 37 ˚C. pH of LB agar base was adjusted using filter sterilized 5M HCl and NaOH. pH 
strips were used to confirm ideal pH levels. Samples were plated in triplicate and 
incubated at 37 ˚C for 48 hours. After incubation, plaques were averaged to be used in 
titer calculations.  
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Results 
Lysate was calculated to be at a titer of 2.2x108 pfu/ml (Figure 1). This titer was 
used in all future experiments as a control. The completed standard curve of M. 
smegmatis (Figure 2) provides the number of colony forming units (CFU) in relation to 
the OD value of the sample. This value can be used to calculate PFU to determine 
multiplicity of infection (MOI) of a sample. This value indicates the number of active 
plaque forming units per cell in a sample. These data indicate that when M. smegmatis 
reaches an OD600 of 0.25 there are approximately 370,000 colony forming units (CFU) in 
solution (Figure 2).  
In order to observe typical replication kinetics of phage Cepens, a one-step 
growth curve was attempted. This procedure did not provide a clear plaque pattern 
despite many attempts (Figure 3). Therefore, the results from this test are not reliable in 
indicating phage infection kinetics.  Since the results from the one step bacteriophage 
growth curve were discounted, the baseline titer calculation under standard conditions 
will be used to indicate variability in infection.  
Statistical analysis using a single factor ANOVA was performed to determine if 
environmental conditions lead to a significant change in infectivity. Samples that 
indicated a significant difference were then tested using a Tukey’s HSD post hoc 
analysis. Any pairwise comparison which indicated significant difference from baseline 
conditions are indicated by an asterisk on the corresponding figure. Error bars on each 
figure represent the calculated standard error of data collected.  
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The titer of plaques observed indicates that exposure of Cepens lysate to 
temperatures above 4˚C leads to a trend wise decrease in infectivity (Figure 4). Statistical 
analysis shows that samples exposed to 45˚, 55˚, and 65˚ C have a p-value < 0.05 
indicating significant difference when compared to the control. Cepens also demonstrated 
an observed decrease in infectivity after exposure to pH below 5.5 or above 9.5 before 
infection (Figure 5). Results from statistical analysis indicate that exposure to pH of 2.0-
3.0 before infection results in a statistically significant p-value < 0.05. The effect of 
incubation temperatures during infection indicate that Cepens requires a temperature of 
30˚C for maximum infectivity (Figure 6). This effect could be due to inhibition of growth 
of host cells or inhibition of infection kinetics of the virus. This data showed a                
p-value < 0.05 after exposure to 25˚, 30˚, 45˚, and 50˚C when compared to the baseline 
infection temperature. When testing the effect of pH on infection, a minimal trend wise 
decrease in titer was observed on plates with pH above 6.0 (Figure 7). However, after 
analysis of the data it did not indicate a significant difference in infectivity.  
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Figures 
  
Figure 1. 1:10 serial dilution of phage lysate was completed. 
Plaques were counted from plate showing abundant individual 
plaques and used to calculate titer.  
Figure 2. Cells were incubated and shaken at 
37°C. Samples were analyzed at dilutions of 
1:400-1:1600 for OD600 and colonies were 
counted using the quadrant method. 
Figure 3. Initial plaques (on the left) are frequent and small in size but not overlapping. Over subsequent plates begin to 
overlap and plaque number increases in size and number. Plaque presence is not clear and indicative of the expected viral 
lifecycle pattern.  
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Figure 7. Infection of M. smegmatis by 
Cepens was performed on plates with pH 5.0-
8.1 in triplicate. After plating, samples were 
incubated at 37°C for 48 hours and then 
plaques were counted for titer calculation. 
Figure 5. To determine the pH stability 
of Cepens, lysate was exposed to pH 
1,2,3,5,7,9,10 and then plated in 
triplicate. Plaques were then counted for 
titer calculation and comparison. 
Extreme pH shows decrease in titer 
values. * indicates statistical 
significance after post hoc analysis. 
Figure 4. To determine the temperature 
stability of Cepens, lysate at 10-5 pfu/ml was 
exposed to 4˚C, 37˚C, 45˚C, 55˚C, and 65˚C 
for two hours. After exposure, each aliquot 
was cooled to 4˚C and then plated in 
triplicate. Plaques were counted for titer 
calculation and comparison. Increasing 
temperature decreases titer value. * indicates 
statistical significance after post hoc analysis. 
Figure 6. To determine the effects of 
variations in temperature on 
infection, lysate was plated in 
triplicate and then incubated in 25, 
30˚, 37˚, 45˚, and 50˚ C. After 
incubation plaques were counted and 
variations in titer were calculated.     
* indicates statistical significance 
after post hoc analysis.  
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Conclusion 
The data in this study provide insights into the proper storage of Cepens lysate as 
well as possible limitations on delivery of phage to a patient. Cepens was sensitive to 
temperatures outside of the host cell. This indicated potential difficulty of lysate storage 
for therapeutic use without the presence of climate control mechanisms. Cepens was also 
highly sensitive to changes in pH outside of the host cell, which would suggest this 
organism could not be delivered orally for therapeutics. However, pH did not seem to 
inhibit replication of the virus within the host. Finally, Cepens replicates optimally 
outside the natural human body temperature but it is still able to produce a successful 
infection at that temperature. While there is limited data from the single round of 
experiments completed here, the data collected does suggest mycobacteriophage similar 
to Cepens could have the capability of therapeutic use under the right conditions. 
Repeating this study with Cepens and other mycobacteriophage and their pathogenic 
hosts could lead to major breakthroughs in the conditions required to maintain proper 
host interactions during bacteriophage therapy.  
The potentials for utilization of bacteriophage for medical and environmental use 
are vast. Bacteriophages are one of the most abundant organisms on earth, but there are 
still vast amounts that have yet to be isolated3. Therefore, continuing studies on new 
bacteriophages could lead to genetic and medical breakthroughs that will change the way 
we treat diseases all around the world. Knowing how to use the host specificity and 
efficiency of bacteriophages could result in quicker and safer patient treatment as well as 
additional treatment of antibiotic resistant microorganisms. There are still concerns of 
potentially negative transduction events during therapeutic use; but furthering the 
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understanding of mycobacteriophage will lead to a better understanding of the 
relationship between phage and pathogenic mycobacterial hosts M. tuberculosis and M. 
Leprae.  
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